Review evidence and expert opinion regarding choice of therapy and sequencing of prostate cancer therapies as early stage prostate cancer patients progress to metastatic disease |
|
|
|
|
|
Engage community clinicians (medical oncology, urology and others) with subject matter experts in the determination of best practices in the management of advanced prostate cancer in the community setting |
|
|
|
|
|
Determine baseline knowledge of recent evidence of import to the optimal management of advanced prostate cancer and compare with expert opinion |
|
|
|
|
|
Increase awareness of and participation in multidisciplinary management of advanced prostate cancer |
|
|
|
|
|
Identify barriers to implementation of best practices by individual clinicians and develop customized approaches to overcoming barriers |
|
|
|
|
|
Reinforce learning and expand participants through community site-based Tumor Boards orchestrated by content experts |
|
|
|
|
|